Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor

Clinical trial NCT00889525 · COMPLETED

Trial details

NCT number: NCT00889525
Sponsor: Seth Gordhandas Sunderdas Medical College
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cushing's Disease Corticotroph Adenoma

Start date: 2007-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.